Olympus OCPNF Stock
Olympus Price Chart
Olympus OCPNF Financial and Trading Overview
| Olympus stock price | 10.01 USD |
| Previous Close | 11.18 USD |
| Open | 10.01 USD |
| Bid | 9.79 USD x 30000 |
| Ask | 10.99 USD x 30000 |
| Day's Range | 10.01 - 10.01 USD |
| 52 Week Range | 8 - 14 USD |
| Volume | 100 USD |
| Avg. Volume | 2.81K USD |
| Market Cap | 10.63B USD |
| Beta (5Y Monthly) | 0.209 |
| PE Ratio (TTM) | 26.342106 |
| EPS (TTM) | 0.38 USD |
| Forward Dividend & Yield | 0.19 (1.90%) |
| Ex-Dividend Date | March 30, 2027 |
| 1y Target Est | N/A |
OCPNF Valuation Measures
| Enterprise Value | 62.56B USD |
| Trailing P/E | 26.342106 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 3.16 |
| Price/Sales (ttm) | 0.010519894 |
| Price/Book (mrq) | 2.1899433 |
| Enterprise Value/Revenue | 0.062 |
| Enterprise Value/EBITDA | 0.303 |
Trading Information
Olympus Stock Price History
| Beta (5Y Monthly) | 0.209 |
| 52-Week Change | -24.33% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 14 USD |
| 52 Week Low | 8 USD |
| 50-Day Moving Average | 10.25 USD |
| 200-Day Moving Average | 11.34 USD |
OCPNF Share Statistics
| Avg. Volume (3 month) | 2.81K USD |
| Avg. Daily Volume (10-Days) | 90 USD |
| Shares Outstanding | 1.06B |
| Float | 1.1B |
| Short Ratio | N/A |
| % Held by Insiders | 4.26% |
| % Held by Institutions | 59.43% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 30 |
| Trailing Annual Dividend Yield | 268.33% |
| 5 Year Average Dividend Yield | 89.00% |
| Payout Ratio | 0.4902 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 6.74% |
| Operating Margin (ttm) | 16.85% |
| Gross Margin | 64.71% |
| EBITDA Margin | 20.46% |
Management Effectiveness
| Return on Assets (ttm) | 5.87% |
| Return on Equity (ttm) | 8.71% |
Income Statement
| Revenue (ttm) | 1.01T USD |
| Revenue Per Share (ttm) | 909.06 USD |
| Quarterly Revenue Growth (yoy) | 8.50% |
| Gross Profit (ttm) | 654.09B USD |
| EBITDA | 206.79B USD |
| Net Income Avi to Common (ttm) | 68.17B USD |
| Diluted EPS (ttm) | 0.38 |
| Quarterly Earnings Growth (yoy) | -40.20% |
Balance Sheet
| Total Cash (mrq) | 188.04B USD |
| Total Cash Per Share (mrq) | 170.77 USD |
| Total Debt (mrq) | 239.58B USD |
| Total Debt/Equity (mrq) | 29.5 USD |
| Current Ratio (mrq) | 1.617 |
| Book Value Per Share (mrq) | 4.5708947 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 100.58B USD |
| Levered Free Cash Flow (ttm) | 1.49B USD |
Profile of Olympus
| Country | United States |
| State | N/A |
| City | Hachioji |
| Address | 2951 Ishikawa-machi |
| ZIP | 192-8507 |
| Phone | 81 42 642 2111 |
| Website | https://www.olympus.co.jp |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
Q&A For Olympus Stock
What is a current OCPNF stock price?
Olympus OCPNF stock price today per share is 10.01 USD.
How to purchase Olympus stock?
You can buy OCPNF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Olympus?
The stock symbol or ticker of Olympus is OCPNF.
Which industry does the Olympus company belong to?
The Olympus industry is Medical Devices.
How many shares does Olympus have in circulation?
The max supply of Olympus shares is 1.06B.
What is Olympus Price to Earnings Ratio (PE Ratio)?
Olympus PE Ratio is 26.34210600 now.
What was Olympus earnings per share over the trailing 12 months (TTM)?
Olympus EPS is 0.38 USD over the trailing 12 months.
Which sector does the Olympus company belong to?
The Olympus sector is Healthcare.